Jim Cramer on Moderna, Inc. (MRNA): ‘The Numbers Here Are Staggering, Staggeringly Bad’
We recently compiled a list of the 10 S&P 500 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at ...
FiercePharma8h
Fierce Pharma Asia—A $410M obesity debut; Another Roche ADC deal; Legend, BeiGene as buyout targets?
A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop ...